TD Waterhouse Canada’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
TD Waterhouse Canada's GILD Position: Q2 2026 in Review
TD Waterhouse Canada reduced its Gilead Sciences (GILD) stake by 13% in Q2 2026, selling an estimated $9.3M and leaving 482,201 shares worth $60.8M. The position accounts for 0.16% of the portfolio, ranked #104.
TD Waterhouse Canada first reported a position in GILD in Q4 2021 and has held it in 19 quarters since. The position peaked at $77.4M in Q1 2026. 1,412 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- TD Waterhouse Canada held 482,201 shares of Gilead Sciences worth $60.8M as of Q2 2026.
- TD Waterhouse Canada sold 70,572 Gilead Sciences shares in Q2 2026, an estimated $9.3M.
- Gilead Sciences made up 0.16% of TD Waterhouse Canada's portfolio in Q2 2026, its #104 holding.
- TD Waterhouse Canada first reported a position in Gilead Sciences in Q4 2021 and has held it in 19 quarters since.
- TD Waterhouse Canada's Gilead Sciences position peaked at $77.4M in Q1 2026.
- 1,412 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on TD Waterhouse Canada's 13F filing for Q2 2026, filed 27 Jul 2026.